Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma Stockholders

Regulation
โดย GlobeNewswire·Read original
Summary · why it matters

Abbott Cooper PLLC has announced an investigation into potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. The investigation seeks to determine whether Estrella's board of directors violated its fiduciary duties or committed other wrongdoing. Estrella's common stock is listed on Nasdaq under the symbol ESLA. Stockholders interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation.

Impact on stocks 1

Biotech & Genomic Medicine▼ · 1 stocks
© 2026 MarketDXNews